According to the research report published by Market IntelliX, the global market for Anticonvulsant Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Anticonvulsant Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Anticonvulsant Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Anxiety has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Anticonvulsant Drug include GlaxoSmithKline Plc, Astellas Pharma Technologies, Valeant Pharmaceuticals N.A, Bausch Health Companies, Watson Laboratories, Abbott Laboratories, Teva Pharmaceutical Industries, Johnson & Johnson and Novartis AG, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

The anticonvulsant drug is a type of drug that is used to prevent or treat seizures or convulsions by controlling abnormal electrical activity in the brain.

This report aims to provide a comprehensive study of the global market for Anticonvulsant Drug. Report Highlights:

(1) Global Anticonvulsant Drug market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Anticonvulsant Drug market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(3) China Anticonvulsant Drug market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(4) Global Anticonvulsant Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Anticonvulsant Drug segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Anticonvulsant Drug, capacity, production and trends.

(7) Anticonvulsant Drug industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)

Barbiturate

Benzodiazepine

Carbamate Anticonvulsants

Carbonic Anhydrase Inhibitor

Dibenzazepine

Triazine

Market segment by application, can be divided into

Anxiety

Bipolar Disorder

Borderline Personality Disorder

Epilepsy

Fibromyalgia

Migraine

Neuropathic Pain

Others

Market segment by players, this report covers

GlaxoSmithKline Plc

Astellas Pharma Technologies

Valeant Pharmaceuticals N.A

Bausch Health Companies

Watson Laboratories

Abbott Laboratories

Teva Pharmaceutical Industries

Johnson & Johnson

Novartis AG

Pfizer

Shire Plc

UCB Group

Huazhong Pharmaceutical Company Limited

Changzhou Siyao Pharmaceutical

Shandong Xinyi Pharmaceutical

1 Market Overview

1.1 Anticonvulsant Drug Definition

1.2 Global Anticonvulsant Drug Market Size and Forecast

1.2.1 By Revenue, Global Anticonvulsant Drug Market Size, 2018-2029

1.2.2 By Sales Volume, Global Anticonvulsant Drug Market Size, 2018-2029

1.2.3 Global Anticonvulsant Drug Price Trend, 2018-2029

1.3 China Anticonvulsant Drug Market Size and Forecast

1.3.1 By Revenue, China Anticonvulsant Drug Market Size, 2018-2029

1.3.2 By Sales Volume, China Anticonvulsant Drug Market Size, 2018-2029

1.3.3 China Anticonvulsant Drug Price Trend, 2018-2029

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Anticonvulsant Drug Share in Global Market, 2018-2029

1.4.2 By Sales Volume, China Anticonvulsant Drug Share in Global Market, 2018-2029

1.4.3 Anticonvulsant Drug Market Size: China VS Global, 2018-2029

1.5 Anticonvulsant Drug Market Dynamics

1.5.1 Anticonvulsant Drug Market Drivers

1.5.2 Anticonvulsant Drug Market Restraints

1.5.3 Anticonvulsant Drug Industry Trends

1.5.4 Anticonvulsant Drug Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Anticonvulsant Drug Revenue by Company, 2018-2023

2.2 Global Anticonvulsant Drug Sales Volume by Company, 2018-2023

2.3 Global Anticonvulsant Drug Price by Company, 2018-2023

2.4 Global Anticonvulsant Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Anticonvulsant Drug Concentration Ratio

2.6 Global Anticonvulsant Drug Mergers & Acquisitions, Expansion Plans

2.7 Global Anticonvulsant Drug Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Anticonvulsant Drug Revenue by Company, 2018-2023

3.2 China Anticonvulsant Drug Sales Volume by Company, 2018-2023

3.3 China Anticonvulsant Drug Anticonvulsant Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Anticonvulsant Drug Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)

3.5 Chinese Local Players, Anticonvulsant Drug Domestic VS Export

3.6 China Market, Anticonvulsant Drug Import & Export

3.6.1 China Market, Anticonvulsant Drug Import & Export, 2018-2029

3.6.2 China Anticonvulsant Drug Import & Export Trends

3.6.3 Main Sources of China Anticonvulsant Drug Import

3.6.4 Export Destination of China Anticonvulsant Drug

4 Anticonvulsant Drug Production by Region

4.1 Global Anticonvulsant Drug Capacity, Production and Capacity Utilization, 2018-2029

4.2 Global Geographic Distribution of Anticonvulsant Drug Manufacturers

4.3 Global Major Manufacturers, Anticonvulsant Drug Capacity Expansion and Future Plans

4.4 Global Anticonvulsant Drug Capacity by Region

4.5 Global Anticonvulsant Drug Production by Region

4.5.1 Global Anticonvulsant Drug Production & Forecast by Region, 2018 VS 2022 VS 2029

4.5.2 Global Anticonvulsant Drug Production by Region, 2018-2023

4.5.3 Global Anticonvulsant Drug Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 Anticonvulsant Drug Industry Chain

5.2 Anticonvulsant Drug Upstream Analysis

5.2.1 Anticonvulsant Drug Core Raw Materials

5.2.2 Main Manufacturers of Anticonvulsant Drug Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Anticonvulsant Drug Production Mode

5.6 Anticonvulsant Drug Procurement Model

5.7 Anticonvulsant Drug Industry Sales Model and Sales Channels

5.7.1 Anticonvulsant Drug Sales Model

5.7.2 Anticonvulsant Drug Typical Distributors

6 Sights by Type

6.1 Anticonvulsant Drug Classification

6.1.1 α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)

6.1.2 Barbiturate

6.1.3 Benzodiazepine

6.1.4 Carbamate Anticonvulsants

6.1.5 Carbonic Anhydrase Inhibitor

6.1.6 Dibenzazepine

6.1.7 Triazine

6.2 By Type, Global Anticonvulsant Drug Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global Anticonvulsant Drug Revenue, 2018-2029

6.4 By Type, Global Anticonvulsant Drug Sales Volume, 2018-2029

6.5 By Type, Global Anticonvulsant Drug Price, 2018-2029

7 Sights by Application

7.1 Anticonvulsant Drug Segment by Application

7.1.1 Anxiety

7.1.2 Bipolar Disorder

7.1.3 Borderline Personality Disorder

7.1.4 Epilepsy

7.1.5 Fibromyalgia

7.1.6 Migraine

7.1.7 Neuropathic Pain

7.1.8 Others

7.2 By Application, Global Anticonvulsant Drug Market Size & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global Anticonvulsant Drug Revenue, 2018-2029

7.4 By Application, Global Anticonvulsant Drug Sales Volume, 2018-2029

7.5 By Application, Global Anticonvulsant Drug Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global Anticonvulsant Drug Market Size, 2018 VS 2022 VS 2029

8.2 By Region, Global Anticonvulsant Drug Revenue, 2018-2029

8.3 By Region, Global Anticonvulsant Drug Sales Volume, 2018-2029

8.4 North America

8.4.1 North America Anticonvulsant Drug Market Size & Forecasts, 2018-2029

8.4.2 By Country, North America Anticonvulsant Drug Market Size Market Share

8.5 Europe

8.5.1 Europe Anticonvulsant Drug Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe Anticonvulsant Drug Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Anticonvulsant Drug Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific Anticonvulsant Drug Market Size Market Share

8.7 South America

8.7.1 South America Anticonvulsant Drug Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America Anticonvulsant Drug Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Anticonvulsant Drug Market Size & CAGR，2018 VS 2022 VS 2029

9.2 By Country, Global Anticonvulsant Drug Revenue, 2018-2029

9.3 By Country, Global Anticonvulsant Drug Sales Volume, 2018-2029

9.4 U.S.

9.4.1 U.S. Anticonvulsant Drug Market Size, 2018-2029

9.4.2 By Company, U.S. Anticonvulsant Drug Sales Volume Market Share, 2022

9.4.3 By Type, U.S. Anticonvulsant Drug Market Size, Share, 2022 VS 2029

9.4.4 By Application, U.S. Anticonvulsant Drug Market Size, Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Anticonvulsant Drug Market Size, 2018-2029

9.5.2 By Company, Europe Anticonvulsant Drug Sales Volume Market Share, 2022

9.5.3 By Type, Europe Anticonvulsant Drug Market Size, Share, 2022 VS 2029

9.5.4 By Application, Europe Anticonvulsant Drug Market Size, Share, 2022 VS 2029

9.6 China

9.6.1 China Anticonvulsant Drug Market Size, 2018-2029

9.6.2 By Company, China Anticonvulsant Drug Sales Volume Market Share, 2022

9.6.3 By Type, China Anticonvulsant Drug Market Size, Share, 2022 VS 2029

9.6.4 By Application, China Anticonvulsant Drug Market Size, Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Anticonvulsant Drug Market Size, 2018-2029

9.7.2 By Company, Japan Anticonvulsant Drug Sales Volume Market Share, 2022

9.7.3 By Type, Japan Anticonvulsant Drug Market Size, Share, 2022 VS 2029

9.7.4 By Application, Japan Anticonvulsant Drug Market Size, Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Anticonvulsant Drug Market Size, 2018-2029

9.8.2 By Company, South Korea Anticonvulsant Drug Sales Volume Market Share, 2022

9.8.3 By Type, South Korea Anticonvulsant Drug Market Size, Share, 2022 VS 2029

9.8.4 By Application, South Korea Anticonvulsant Drug Market Size, Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Anticonvulsant Drug Market Size, 2018-2029

9.9.2 By Company, Southeast Asia Anticonvulsant Drug Sales Volume Market Share, 2022

9.9.3 By Type, Southeast Asia Anticonvulsant Drug Market Size, Share, 2022 VS 2029

9.9.4 By Application, Southeast Asia Anticonvulsant Drug Market Size, Share, 2022 VS 2029

9.10 India

9.10.1 India Anticonvulsant Drug Market Size, 2018-2029

9.10.2 By Company, India Anticonvulsant Drug Sales Volume Market Share, 2022

9.10.3 By Type, India Anticonvulsant Drug Market Size, Share, 2022 VS 2029

9.10.4 By Application, India Anticonvulsant Drug Market Size, Share, 2022 VS 2029

9.11 Middle East & Asia

9.11.1 Middle East & Asia Anticonvulsant Drug Market Size, 2018-2029

9.11.2 By Company, Middle East & Asia Anticonvulsant Drug Sales Volume Market Share, 2022

9.11.3 By Type, Middle East & Asia Anticonvulsant Drug Market Size, Share, 2022 VS 2029

9.11.4 By Application, Middle East & Asia Anticonvulsant Drug Market Size, Share, 2022 VS 2029

10 Manufacturers Profile

10.1 GlaxoSmithKline Plc

10.1.1 GlaxoSmithKline Plc Company Information, Head Office, Market Area and Industry Position

10.1.2 GlaxoSmithKline Plc Anticonvulsant Drug Models, Specifications and Application

10.1.3 GlaxoSmithKline Plc Anticonvulsant Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.1.4 GlaxoSmithKline Plc Company Profile and Main Business

10.1.5 GlaxoSmithKline Plc Recent Developments

10.2 Astellas Pharma Technologies

10.2.1 Astellas Pharma Technologies Company Information, Head Office, Market Area and Industry Position

10.2.2 Astellas Pharma Technologies Anticonvulsant Drug Models, Specifications and Application

10.2.3 Astellas Pharma Technologies Anticonvulsant Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.2.4 Astellas Pharma Technologies Company Profile and Main Business

10.2.5 Astellas Pharma Technologies Recent Developments

10.3 Valeant Pharmaceuticals N.A

10.3.1 Valeant Pharmaceuticals N.A Company Information, Head Office, Market Area and Industry Position

10.3.2 Valeant Pharmaceuticals N.A Anticonvulsant Drug Models, Specifications and Application

10.3.3 Valeant Pharmaceuticals N.A Anticonvulsant Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.3.4 Valeant Pharmaceuticals N.A Company Profile and Main Business

10.3.5 Valeant Pharmaceuticals N.A Recent Developments

10.4 Bausch Health Companies

10.4.1 Bausch Health Companies Company Information, Head Office, Market Area and Industry Position

10.4.2 Bausch Health Companies Anticonvulsant Drug Models, Specifications and Application

10.4.3 Bausch Health Companies Anticonvulsant Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.4.4 Bausch Health Companies Company Profile and Main Business

10.4.5 Bausch Health Companies Recent Developments

10.5 Watson Laboratories

10.5.1 Watson Laboratories Company Information, Head Office, Market Area and Industry Position

10.5.2 Watson Laboratories Anticonvulsant Drug Models, Specifications and Application

10.5.3 Watson Laboratories Anticonvulsant Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.5.4 Watson Laboratories Company Profile and Main Business

10.5.5 Watson Laboratories Recent Developments

10.6 Abbott Laboratories

10.6.1 Abbott Laboratories Company Information, Head Office, Market Area and Industry Position

10.6.2 Abbott Laboratories Anticonvulsant Drug Models, Specifications and Application

10.6.3 Abbott Laboratories Anticonvulsant Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.6.4 Abbott Laboratories Company Profile and Main Business

10.6.5 Abbott Laboratories Recent Developments

10.7 Teva Pharmaceutical Industries

10.7.1 Teva Pharmaceutical Industries Company Information, Head Office, Market Area and Industry Position

10.7.2 Teva Pharmaceutical Industries Anticonvulsant Drug Models, Specifications and Application

10.7.3 Teva Pharmaceutical Industries Anticonvulsant Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.7.4 Teva Pharmaceutical Industries Company Profile and Main Business

10.7.5 Teva Pharmaceutical Industries Recent Developments

10.8 Johnson & Johnson

10.8.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

10.8.2 Johnson & Johnson Anticonvulsant Drug Models, Specifications and Application

10.8.3 Johnson & Johnson Anticonvulsant Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.8.4 Johnson & Johnson Company Profile and Main Business

10.8.5 Johnson & Johnson Recent Developments

10.9 Novartis AG

10.9.1 Novartis AG Company Information, Head Office, Market Area and Industry Position

10.9.2 Novartis AG Anticonvulsant Drug Models, Specifications and Application

10.9.3 Novartis AG Anticonvulsant Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.9.4 Novartis AG Company Profile and Main Business

10.9.5 Novartis AG Recent Developments

10.10 Pfizer

10.10.1 Pfizer Company Information, Head Office, Market Area and Industry Position

10.10.2 Pfizer Anticonvulsant Drug Models, Specifications and Application

10.10.3 Pfizer Anticonvulsant Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.10.4 Pfizer Company Profile and Main Business

10.10.5 Pfizer Recent Developments

10.11 Shire Plc

10.11.1 Shire Plc Company Information, Head Office, Market Area and Industry Position

10.11.2 Shire Plc Anticonvulsant Drug Models, Specifications and Application

10.11.3 Shire Plc Anticonvulsant Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.11.4 Shire Plc Company Profile and Main Business

10.11.5 Shire Plc Recent Developments

10.12 UCB Group

10.12.1 UCB Group Company Information, Head Office, Market Area and Industry Position

10.12.2 UCB Group Anticonvulsant Drug Models, Specifications and Application

10.12.3 UCB Group Anticonvulsant Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.12.4 UCB Group Company Profile and Main Business

10.12.5 UCB Group Recent Developments

10.13 Huazhong Pharmaceutical Company Limited

10.13.1 Huazhong Pharmaceutical Company Limited Company Information, Head Office, Market Area and Industry Position

10.13.2 Huazhong Pharmaceutical Company Limited Anticonvulsant Drug Models, Specifications and Application

10.13.3 Huazhong Pharmaceutical Company Limited Anticonvulsant Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.13.4 Huazhong Pharmaceutical Company Limited Company Profile and Main Business

10.13.5 Huazhong Pharmaceutical Company Limited Recent Developments

10.14 Changzhou Siyao Pharmaceutical

10.14.1 Changzhou Siyao Pharmaceutical Company Information, Head Office, Market Area and Industry Position

10.14.2 Changzhou Siyao Pharmaceutical Anticonvulsant Drug Models, Specifications and Application

10.14.3 Changzhou Siyao Pharmaceutical Anticonvulsant Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.14.4 Changzhou Siyao Pharmaceutical Company Profile and Main Business

10.14.5 Changzhou Siyao Pharmaceutical Recent Developments

10.15 Shandong Xinyi Pharmaceutical

10.15.1 Shandong Xinyi Pharmaceutical Company Information, Head Office, Market Area and Industry Position

10.15.2 Shandong Xinyi Pharmaceutical Anticonvulsant Drug Models, Specifications and Application

10.15.3 Shandong Xinyi Pharmaceutical Anticonvulsant Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.15.4 Shandong Xinyi Pharmaceutical Company Profile and Main Business

10.15.5 Shandong Xinyi Pharmaceutical Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Anticonvulsant Drug Market Size & CAGR: China VS Global, 2018-2029, US$ Million_x000D_

Table 2. Anticonvulsant Drug Market Restraints_x000D_

Table 3. Anticonvulsant Drug Market Trends_x000D_

Table 4. Anticonvulsant Drug Industry Policy_x000D_

Table 5. Global Anticonvulsant Drug Revenue by Company, 2018-2023, US$ million_x000D_

Table 6. Global Anticonvulsant Drug Revenue Market Share by Company, 2018-2023_x000D_

Table 7. Global Anticonvulsant Drug Sales Volume by Company, 2018-2023, (K Units)_x000D_

Table 8. Global Anticonvulsant Drug Sales Volume Market Share by Company, 2018-2023_x000D_

Table 9. Global Anticonvulsant Drug Price by Company, 2018-2023, (US$/Unit)_x000D_

Table 10. Global Anticonvulsant Drug Manufacturers Market Concentration Ratio (CR3 and HHI)_x000D_

Table 11. Global Anticonvulsant Drug Mergers & Acquisitions, Expansion Plans_x000D_

Table 12. Global Anticonvulsant Drug Manufacturers Product Type_x000D_

Table 13. China Anticonvulsant Drug Revenue by Company, 2018-2023, US$ million_x000D_

Table 14. China Anticonvulsant Drug Revenue Market Share by Company, 2018-2023_x000D_

Table 15. China Anticonvulsant Drug Sales Volume by Company, 2018-2023, (K Units)_x000D_

Table 16. China Anticonvulsant Drug Sales Volume Market Share by Company, 2018-2023_x000D_

Table 17. China Market, Anticonvulsant Drug Production, Sales, Import and Export, 2018-2029, (K Units)_x000D_

Table 18. China Anticonvulsant Drug Import & Export Trends_x000D_

Table 19. Main Sources of China Anticonvulsant Drug Import_x000D_

Table 20. Export Destination of China Anticonvulsant Drug_x000D_

Table 21. Global Headquarters and Manufacturing Base of Anticonvulsant Drug Manufacturers_x000D_

Table 22. Global Major Manufacturers, Anticonvulsant Drug Capacity Expansion and Future Plans_x000D_

Table 23. Global Anticonvulsant Drug Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)_x000D_

Table 24. Global Anticonvulsant Drug Production by Region, 2018-2023, (K Units)_x000D_

Table 25. Global Anticonvulsant Drug Production Forecast by Region, 2023-2029, (K Units)_x000D_

Table 26. Global Key Players of Anticonvulsant Drug Upstream (Raw Materials)_x000D_

Table 27. Global Anticonvulsant Drug Typical Customers_x000D_

Table 28. Anticonvulsant Drug Typical Distributors_x000D_

Table 29. By Type, Global Anticonvulsant Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million_x000D_

Table 30. By Application, Global Anticonvulsant Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million_x000D_

Table 31. By Region, Global Anticonvulsant Drug Market Size, 2018 VS 2022 VS 2029, US$ Million_x000D_

Table 32. By Region, Global Anticonvulsant Drug Revenue, 2018-2029, US$ Million_x000D_

Table 33. By Region, Global Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)_x000D_

Table 34. By Country, Global Anticonvulsant Drug Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million_x000D_

Table 35. By Country, Global Anticonvulsant Drug Revenue, 2018-2029, US$ Million_x000D_

Table 36. By Country, Global Anticonvulsant Drug Revenue Market Share, 2018-2029_x000D_

Table 37. By Country, Global Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)_x000D_

Table 38. By Country, Global Anticonvulsant Drug Sales Volume Market Share, 2018-2029_x000D_

Table 39. GlaxoSmithKline Plc Company Information, Head Office, Market Area and Industry Position_x000D_

Table 40. GlaxoSmithKline Plc Anticonvulsant Drug Models, Specifications and Application_x000D_

Table 41. GlaxoSmithKline Plc Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 42. GlaxoSmithKline Plc Company Profile and Main Business_x000D_

Table 43. GlaxoSmithKline Plc Recent Developments_x000D_

Table 44. Astellas Pharma Technologies Company Information, Head Office, Market Area and Industry Position_x000D_

Table 45. Astellas Pharma Technologies Anticonvulsant Drug Models, Specifications and Application_x000D_

Table 46. Astellas Pharma Technologies Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 47. Astellas Pharma Technologies Company Profile and Main Business_x000D_

Table 48. Astellas Pharma Technologies Recent Developments_x000D_

Table 49. Valeant Pharmaceuticals N.A Company Information, Head Office, Market Area and Industry Position_x000D_

Table 50. Valeant Pharmaceuticals N.A Anticonvulsant Drug Models, Specifications and Application_x000D_

Table 51. Valeant Pharmaceuticals N.A Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 52. Valeant Pharmaceuticals N.A Company Profile and Main Business_x000D_

Table 53. Valeant Pharmaceuticals N.A Recent Developments_x000D_

Table 54. Bausch Health Companies Company Information, Head Office, Market Area and Industry Position_x000D_

Table 55. Bausch Health Companies Anticonvulsant Drug Models, Specifications and Application_x000D_

Table 56. Bausch Health Companies Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 57. Bausch Health Companies Company Profile and Main Business_x000D_

Table 58. Bausch Health Companies Recent Developments_x000D_

Table 59. Watson Laboratories Company Information, Head Office, Market Area and Industry Position_x000D_

Table 60. Watson Laboratories Anticonvulsant Drug Models, Specifications and Application_x000D_

Table 61. Watson Laboratories Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 62. Watson Laboratories Company Profile and Main Business_x000D_

Table 63. Watson Laboratories Recent Developments_x000D_

Table 64. Abbott Laboratories Company Information, Head Office, Market Area and Industry Position_x000D_

Table 65. Abbott Laboratories Anticonvulsant Drug Models, Specifications and Application_x000D_

Table 66. Abbott Laboratories Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 67. Abbott Laboratories Company Profile and Main Business_x000D_

Table 68. Abbott Laboratories Recent Developments_x000D_

Table 69. Teva Pharmaceutical Industries Company Information, Head Office, Market Area and Industry Position_x000D_

Table 70. Teva Pharmaceutical Industries Anticonvulsant Drug Models, Specifications and Application_x000D_

Table 71. Teva Pharmaceutical Industries Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 72. Teva Pharmaceutical Industries Company Profile and Main Business_x000D_

Table 73. Teva Pharmaceutical Industries Recent Developments_x000D_

Table 74. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position_x000D_

Table 75. Johnson & Johnson Anticonvulsant Drug Models, Specifications and Application_x000D_

Table 76. Johnson & Johnson Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 77. Johnson & Johnson Company Profile and Main Business_x000D_

Table 78. Johnson & Johnson Recent Developments_x000D_

Table 79. Novartis AG Company Information, Head Office, Market Area and Industry Position_x000D_

Table 80. Novartis AG Anticonvulsant Drug Models, Specifications and Application_x000D_

Table 81. Novartis AG Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 82. Novartis AG Company Profile and Main Business_x000D_

Table 83. Novartis AG Recent Developments_x000D_

Table 84. Pfizer Company Information, Head Office, Market Area and Industry Position_x000D_

Table 85. Pfizer Anticonvulsant Drug Models, Specifications and Application_x000D_

Table 86. Pfizer Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 87. Pfizer Company Profile and Main Business_x000D_

Table 88. Pfizer Recent Developments_x000D_

Table 89. Shire Plc Company Information, Head Office, Market Area and Industry Position_x000D_

Table 90. Shire Plc Anticonvulsant Drug Models, Specifications and Application_x000D_

Table 91. Shire Plc Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 92. Shire Plc Company Profile and Main Business_x000D_

Table 93. Shire Plc Recent Developments_x000D_

Table 94. UCB Group Company Information, Head Office, Market Area and Industry Position_x000D_

Table 95. UCB Group Anticonvulsant Drug Models, Specifications and Application_x000D_

Table 96. UCB Group Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 97. UCB Group Company Profile and Main Business_x000D_

Table 98. UCB Group Recent Developments_x000D_

Table 99. Huazhong Pharmaceutical Company Limited Company Information, Head Office, Market Area and Industry Position_x000D_

Table 100. Huazhong Pharmaceutical Company Limited Anticonvulsant Drug Models, Specifications and Application_x000D_

Table 101. Huazhong Pharmaceutical Company Limited Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 102. Huazhong Pharmaceutical Company Limited Company Profile and Main Business_x000D_

Table 103. Huazhong Pharmaceutical Company Limited Recent Developments_x000D_

Table 104. Changzhou Siyao Pharmaceutical Company Information, Head Office, Market Area and Industry Position_x000D_

Table 105. Changzhou Siyao Pharmaceutical Anticonvulsant Drug Models, Specifications and Application_x000D_

Table 106. Changzhou Siyao Pharmaceutical Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 107. Changzhou Siyao Pharmaceutical Company Profile and Main Business_x000D_

Table 108. Changzhou Siyao Pharmaceutical Recent Developments_x000D_

Table 109. Shandong Xinyi Pharmaceutical Company Information, Head Office, Market Area and Industry Position_x000D_

Table 110. Shandong Xinyi Pharmaceutical Anticonvulsant Drug Models, Specifications and Application_x000D_

Table 111. Shandong Xinyi Pharmaceutical Anticonvulsant Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_

Table 112. Shandong Xinyi Pharmaceutical Company Profile and Main Business_x000D_

Table 113. Shandong Xinyi Pharmaceutical Recent Developments_x000D_

List of Figure_x000D_

Figure 1. Anticonvulsant Drug Picture_x000D_

Figure 2. By Revenue, Global Anticonvulsant Drug Market Size and Forecast, 2018-2029, US$ Million_x000D_

Figure 3. By Sales Volume, Global Anticonvulsant Drug Market Size and Forecast, 2018-2029, (K Units)_x000D_

Figure 4. Global Anticonvulsant Drug Price Trend, 2018-2029, (US$/Unit)_x000D_

Figure 5. By Revenue, China Anticonvulsant Drug Market Size and Forecast, 2018-2029, US$ million_x000D_

Figure 6. By Sales Volume, China Anticonvulsant Drug Market Size and Forecast, 2018-2029, (K Units)_x000D_

Figure 7. China Anticonvulsant Drug Price Trend, 2018-2029 (US$/Unit)_x000D_

Figure 8. By Revenue, China Anticonvulsant Drug Share of Global Market, 2018-2029_x000D_

Figure 9. By Sales Volume, China Anticonvulsant Drug Share of Global Market, 2018-2029_x000D_

Figure 10. Global Anticonvulsant Drug Key Participants, Market Share, 2021 VS 2022 VS 2023_x000D_

Figure 11. Global Anticonvulsant Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022_x000D_

Figure 12. China Anticonvulsant Drug Key Participants, Market Share, 2021 VS 2022 VS 2023_x000D_

Figure 13. China Anticonvulsant Drug Key Participants, Market Share, 2021 VS 2022 VS 2023_x000D_

Figure 14. China Anticonvulsant Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023_x000D_

Figure 15. Chinese Local Players, Proportion of Anticonvulsant Drug Domestic VS Export, 2022_x000D_

Figure 16. Global Anticonvulsant Drug Capacity, Production and Capacity Utilization, 2018-2029_x000D_

Figure 17. Global Anticonvulsant Drug Capacity Market Share by Region, 2022 VS 2029_x000D_

Figure 18. Global Anticonvulsant Drug Production Market Share & Forecast by Region, 2018-2029_x000D_

Figure 19. Anticonvulsant Drug Industry Chain_x000D_

Figure 20. Anticonvulsant Drug Procurement Model_x000D_

Figure 21. Anticonvulsant Drug Sales Model_x000D_

Figure 22. Anticonvulsant Drug Sales Channels, Direct Sales and Distribution_x000D_

Figure 23. α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)_x000D_

Figure 24. Barbiturate_x000D_

Figure 25. Benzodiazepine_x000D_

Figure 26. Carbamate Anticonvulsants_x000D_

Figure 27. Carbonic Anhydrase Inhibitor_x000D_

Figure 28. Dibenzazepine_x000D_

Figure 29. Triazine_x000D_

Figure 30. By Type, Global Anticonvulsant Drug Revenue, 2018-2029, US$ Million_x000D_

Figure 31. By Type, Global Anticonvulsant Drug Revenue Market Share, 2018-2029_x000D_

Figure 32. By Type, Global Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)_x000D_

Figure 33. By Type, Global Anticonvulsant Drug Sales Volume Market Share, 2018-2029_x000D_

Figure 34. By Type, Global Anticonvulsant Drug Price, 2018-2029, (US$/Unit)_x000D_

Figure 35. Anxiety_x000D_

Figure 36. Bipolar Disorder_x000D_

Figure 37. Borderline Personality Disorder_x000D_

Figure 38. Epilepsy_x000D_

Figure 39. Fibromyalgia_x000D_

Figure 40. Migraine_x000D_

Figure 41. Neuropathic Pain_x000D_

Figure 42. Others_x000D_

Figure 43. By Application, Global Anticonvulsant Drug Revenue, 2018-2029, US$ Million_x000D_

Figure 44. By Application, Global Anticonvulsant Drug Revenue Market Share, 2018-2029_x000D_

Figure 45. By Application, Global Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)_x000D_

Figure 46. By Application, Global Anticonvulsant Drug Sales Volume Market Share, 2018-2029_x000D_

Figure 47. By Application, Global Anticonvulsant Drug Price, 2018-2029, (US$/Unit)_x000D_

Figure 48. By Region, Global Anticonvulsant Drug Revenue Market Share, 2018-2029_x000D_

Figure 49. By Region, Global Anticonvulsant Drug Sales Volume Market Share, 2018-2029_x000D_

Figure 50. North America Anticonvulsant Drug Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 51. By Country, North America Anticonvulsant Drug Revenue Market Share, 2022_x000D_

Figure 52. Europe Anticonvulsant Drug Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 53. By Country, Europe Anticonvulsant Drug Revenue Market Share, 2022_x000D_

Figure 54. Asia Pacific Anticonvulsant Drug Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 55. By Country/Region, Asia Pacific Anticonvulsant Drug Revenue Market Share, 2022_x000D_

Figure 56. South America Anticonvulsant Drug Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 57. By Country, South America Anticonvulsant Drug Revenue Market Share, 2022_x000D_

Figure 58. Middle East & Africa Anticonvulsant Drug Revenue & Forecasts, 2018-2029, US$ Million_x000D_

Figure 59. U.S. Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)_x000D_

Figure 60. By Company, U.S. Anticonvulsant Drug Market Share, 2022_x000D_

Figure 61. By Type, U.S. Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 62. By Application, U.S. Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 63. Europe Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)_x000D_

Figure 64. By Company, Europe Anticonvulsant Drug Market Share, 2022_x000D_

Figure 65. By Type, Europe Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 66. By Application, Europe Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 67. China Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)_x000D_

Figure 68. By Company, China Anticonvulsant Drug Market Share, 2022_x000D_

Figure 69. By Type, China Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 70. By Application, China Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 71. Japan Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)_x000D_

Figure 72. By Company, Japan Anticonvulsant Drug Market Share, 2022_x000D_

Figure 73. By Type, Japan Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 74. By Application, Japan Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 75. South Korea Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)_x000D_

Figure 76. By Company, South Korea Anticonvulsant Drug Market Share, 2022_x000D_

Figure 77. By Type, South Korea Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 78. By Application, South Korea Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 79. Southeast Asia Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)_x000D_

Figure 80. By Company, Southeast Asia Anticonvulsant Drug Market Share, 2022_x000D_

Figure 81. By Type, Southeast Asia Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 82. By Application, Southeast Asia Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 83. India Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)_x000D_

Figure 84. By Company, India Anticonvulsant Drug Market Share, 2022_x000D_

Figure 85. By Type, India Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 86. By Application, India Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 87. Middle East & Asia Anticonvulsant Drug Sales Volume, 2018-2029, (K Units)_x000D_

Figure 88. By Company, Middle East & Asia Anticonvulsant Drug Market Share, 2022_x000D_

Figure 89. By Type, Middle East & Asia Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 90. By Application, Middle East & Asia Anticonvulsant Drug Sales Volume Market Share, 2022 VS 2029_x000D_

Figure 91. Research Methodology_x000D_

Figure 92. Breakdown of Primary Interviews_x000D_

Figure 93. Bottom-up Approaches_x000D_

Figure 94. Top-down Approaches_x000D_

_x000D_

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)